CD8A and neoplasm: Of note, the epitope-directed approach to increase the concentration of IL-2 in the tumor as part of a fusion protein (L19-IL2), which was successfully combined with single high-dose RT, also resulted in intratumoral CD8+ T cell expansion with only minimal changes in secondary lymphoid organs.47